Chenodeoxycholic Acid: Clinical Trials

1 trial of Chenodeoxycholic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Withdrawn 1

Follow Chenodeoxycholic Acid: new trials by email Literature Review of Chenodeoxycholic Acid trials Research Report on Chenodeoxycholic Acid

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
Chenodeoxycholic acid, Chenodeoxycholic acid Placebo - Cerebrotendinous Xanthomatoses
Phase 3WithdrawnLeadiant Biosciences, Inc.2024-05-272024-11-18

Conditions studied

Xanthomatosis, Cerebrotendinous (1)

Sponsors

Leadiant Biosciences, Inc. (1)

Countries

Israel (1)

NIH funding

2023 (1)